BGI
ASMB icon

B Group Inc’s Assembly Biosciences ASMB Stock Holding History

B Group Inc’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.88M Hold
175,706
– – 3.61% 12
2025
Q4 		$5.98M Hold
175,706
– – 4.41% 9
2025
Q3 		$4.5M Sell
175,706
-13,644
-7% -$299K 3.31% 8
2025
Q2 		$3.43M Sell
189,350
-10,650
-5% -$140K 2.64% 11
2025
Q1 		$1.91M Buy
200,000
+149,349
+295% +$1.95M 1.64% 9
2024
Q4 		$799K Buy
+50,651
New +$815K 0.49% 13

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

B Group Inc's ASMB Position: Q1 2026 in Review

B Group Inc held its Assembly Biosciences (ASMB) position steady in Q1 2026 at 175,706 shares worth $4.88M. The position accounts for 3.61% of the portfolio, ranked #12.

B Group Inc first reported a position in ASMB in Q4 2024 and has held it in 6 quarters since. The position peaked at $5.98M in Q4 2025. 75 funds tracked by Wall St. Rank hold ASMB as of Q1 2026.

  • B Group Inc held 175,706 shares of Assembly Biosciences worth $4.88M as of Q1 2026.
  • B Group Inc left its Assembly Biosciences share count unchanged in Q1 2026.
  • Assembly Biosciences made up 3.61% of B Group Inc's portfolio in Q1 2026, its #12 holding.
  • B Group Inc first reported a position in Assembly Biosciences in Q4 2024 and has held it in 6 quarters since.
  • B Group Inc's Assembly Biosciences position peaked at $5.98M in Q4 2025.
  • 75 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2026.

Based on B Group Inc's 13F filing for Q1 2026, filed 15 May 2026.